Federal study will test combination of remdesivir and multiple sclerosis in coronavirus patients 

Beta interferon is a drug approved to treat multiple sclerosis, has anti-inflammatory properties and has been shown to stop replication of viruses like SARS, and will be tested with remdesivir.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news